Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Twyneo vs Retin-A in acne
NCT04059523Phase 1Completed
- Sponsor
- Sol-Gel Technologies
- Start
- Jun 2019
- Primary completion
- Feb 2020
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of benzoyl peroxide + tretinoin in acne vulgaris (2 arms), sponsored by Sol-Gel Technologies. Primary endpoint: Maximum Observed Plasma Concentration at 14 days. Started Jun 2019; status: completed.
02
Drugs
benzoyl peroxide + tretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT04059523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04059523.